The Effects of an Orally-Administered Probiotic on Vaginal Symptoms

Inclusion Criteria: * Healthy women who are 18-65 years of age (inclusive). * Have a body mass index (BMI) between 18.5 to 29.9 kg/m2 (inclusive). * Experiences vaginal odor. * Maintains study eligibility status during the run-in period (as outlined during the pre-screening period) from screening through the end of the study. * Have no current medical diagnosis of active bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or urinary tract infection (UTI), or any other active infectious, inflammatory, or neoplastic vulvovaginal or genitourinary disorder. * Have not been medically diagnosed with recurrent BV as defined by 3 or more diagnosed infections in the past 12 months, recurrent VVC as defined by 3 or more symptomatic, diagnosed infections in the past 12 months, or recurrent UTIs as defined by 3 or more diagnosed infections in the past year or 2 or more diagnosed infections in the past 6 months. * In good general health (no active or uncontrolled diseases or conditions) and able to consume the study product. * Willing to report information related to your menstrual cycle and menopause status. * Agree to refrain from using probiotic/prebiotic supplements (oral or vaginal); boric acid; pH-balancing tampons, pads, wipes, and washes; antifungals (oral or vaginal); antibiotics, and other treatments listed in Section 6.5 during the defined timeframe. * Agree to refrain from making changes to current level of consumption of foods containing probiotics/prebiotics. * Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures. Exclusion Criteria: * Active infectious, inflammatory, or neoplastic vulvovaginal or genitourinary disorder (such as vulvovaginal candidiasis, bacterial vaginosis, urinary tract infection, vulvar intraepithelial neoplasia, or lichen sclerosis). * Symptomatic sexually transmitted infection. * Use of probiotics within the past 3 months. * Any prior use of intervention product. * Use of antibiotics within the past 3 months. * Vaginal hormone therapy (unless dosage and modality has been stable for 90 days prior to enrollment). * Current use of any medications, supplements, or over-the-counter remedies (including boric acid and deodorants) for vaginal odor. * Vaginal rinses, moisturizers, cooling devices, cooling mattresses, or cooling sprays (unless habitually used for at least 90 days prior to enrollment). * Self-reported urinary incontinence. * Currently lactating, pregnant, or planning to become pregnant during the study period. * Known sensitivity, intolerability, or allergy to any of the study products or their ingredients. * Any clinically significant disease or disorder which, in the opinion of the study investigator, may place you at undue risk or harm, interfere with ability to participate, compromise the interpretability of the study data. * History of alcohol or substance abuse in the last 5 years. * History of smoking in the last 2 years. * Currently participating in another clinical research study on vulvovaginal health.